Publications

  1. Assis MLM, Bojaxhi E, Abode-Iyamah KO, Patterson JS, White KE, Gruenbaum SE, Rabai F, De Ruyter ML, Riutort KT, Fleissner ZJ, Pirris SM, Barbosa M, Gruenbaum BF. The Benefits of Awake Spinal Surgery on Minimizing Positioning-related Complications: A Narrative Review. Spine (Phila Pa 1976). 2025 Apr 15; 50 (8):555-561 Epub 2024 Nov 18
    View PubMed
  2. Rabelo SP, Rodrigues ES, Grewal S, Dutcher J, Barbosa MTP. Face-to-Face Intubation During a Deep Brain Stimulation Surgery: A Case Report. A A Pract. 2025 Apr 1; 19 (4):e01940 Epub 2025 Apr 03
    View PubMed
  3. Bojaxhi E, Louie C, ReFaey K, Gruenbaum SE, Leone BJ, Bechtle P, Barbosa MP, Chaichana KL, Quinones-Hinojosa A. Corrigendum to "Reduced Pain and Opioid Use in the Early Postoperative Period in Patients Undergoing a Frontotemporal Craniotomy under Regional vs General Anesthesia" [World Neurosurgery 150 (June/2021) e31-e37]. World Neurosurg. 2022 Jul; 163:2 Epub 2022 Apr 19
    View PubMed
  4. Bojaxhi E, Louie C, ReFaey K, Gruenbaum SE, Leone BJ, Bechtel P, Barbosa MP, Chaichana KL, Quinones-Hinojosa A. Reduced Pain and Opioid Use in the Early Postoperative Period in Patients Undergoing a Frontotemporal Craniotomy under Regional vs General Anesthesia. World Neurosurg. 2021 Jun; 150:e31-e37 Epub 2021 Mar 05
    View PubMed
  5. Dr.. Informed Consent Anesthesia Education Toolbox. 2019.
  6. Goldstein ED, Schnusenberg L, Mooney L, Raper CC, McDaniel S, Thorpe DA, Franke MT, Anderson LK, McClure LL, Oglesby MM, Lewis CY, Velichko C, Bradley BG, Horn WW Jr, Reid AN, Siegel JL, Cannistraro R, Bechtle P, Barbosa MT, Silvers SM, Brown BL, Freeman WD, Miller DA, Barrett KM, Huang JF. Reducing Door-to-Reperfusion Time for Mechanical Thrombectomy With a Multitiered Notification System for Acute Ischemic Stroke. Mayo Clin Proc Innov Qual Outcomes. 2018 Jun; 2 (2):119-128 Epub 2018 May 24
    View PubMed
  7. Chini CC, Guerrico AM, Nin V, Camacho-Pereira J, Escande C, Barbosa MT, Chini EN. Targeting of NAD metabolism in pancreatic cancer cells: potential novel therapy for pancreatic tumors. Clin Cancer Res. 2014 Jan 1; 20 (1):120-30 Epub 2013 Sept 11
    View PubMed
  8. Escande C, Nin V, Price NL, Capellini V, Gomes AP, Barbosa MT, O'Neil L, White TA, Sinclair DA, Chini EN. Flavonoid apigenin is an inhibitor of the NAD+ ase CD38: implications for cellular NAD+ metabolism, protein acetylation, and treatment of metabolic syndrome. Diabetes. 2013 Apr; 62 (4):1084-93 Epub 2012 Nov 19
    View PubMed
  9. Sahar S, Nin V, Barbosa MT, Chini EN, Sassone-Corsi P. Altered behavioral and metabolic circadian rhythms in mice with disrupted NAD+ oscillation. Aging (Albany NY). 2011 Aug; 3(8):794-802.
    View PubMed
  10. Novak CM, Escande C, Burghardt PR, Zhang M, Barbosa MT, Chini EN, Britton SL, Koch LG, Akil H, Levine JA. Spontaneous activity, economy of activity, and resistance to diet-induced obesity in rats bred for high intrinsic aerobic capacity. Horm Behav. 2010 Aug; 58(3):355-67. Epub 2010 Mar 27.
    View PubMed
  11. Barbosa MT, Soares SM, Novak CM, Sinclair D, Levine JA, Aksoy P, Chini EN. The enzyme CD38 (a NAD glycohydrolase, EC 3.2.2.5) is necessary for the development of diet-induced obesity. FASEB J. 2007 Nov; 21(13):3629-39. Epub 2007 Jun 21.
    View PubMed